REILLY FINANCIAL ADVISORS, LLC - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 18 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
REILLY FINANCIAL ADVISORS, LLC ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2021$1,0000.0%2500.0%0.00%
Q4 2020$1,0000.0%2500.0%0.00%
Q3 2020$1,0000.0%2500.0%0.00%
Q2 2020$1,0000.0%2500.0%0.00%
Q1 2020$1,0000.0%2500.0%0.00%
Q4 2019$1,0000.0%2500.0%0.00%
Q3 2019$1,000
-50.0%
2500.0%0.00%
Q2 2019$2,0000.0%2500.0%0.00%
Q1 2019$2,0000.0%2500.0%0.00%
Q4 2018$2,000
-33.3%
2500.0%0.00%
Q3 2018$3,0000.0%2500.0%0.00%
Q2 2018$3,000
+200.0%
2500.0%0.00%
Q1 2018$1,000
-50.0%
2500.0%0.00%
Q4 2017$2,0000.0%2500.0%0.00%
Q3 2017$2,0000.0%2500.0%0.00%
Q2 2017$2,000
+100.0%
2500.0%0.00%
Q1 2017$1,0000.0%2500.0%0.00%
Q4 2016$1,0000.0%2500.0%0.00%
Q3 2016$1,0000.0%2500.0%0.00%
Q2 2016$1,0000.0%2500.0%0.00%
Q1 2016$1,0002500.00%
Other shareholders
GALMED PHARMACEUTICALS LTD shareholders Q1 2016
NameSharesValueWeighting ↓
Ibex Investors LLC 339,000$4,034,0002.29%
Knoll Capital Management, LLC 210,000$2,499,0002.12%
BVF INC/IL 1,761,567$20,963,0002.05%
Vivo Capital, LLC 792,707$9,433,0001.22%
P.A.W. CAPITAL CORP 95,000$1,131,0001.14%
683 Capital Management, LLC 1,350,000$16,065,0001.09%
Unterberg Capital LLC 50,000$595,0000.70%
SABBY MANAGEMENT, LLC 232,224$2,763,0000.43%
Nantahala Capital Management 741,108$8,819,0000.36%
DAFNA Capital Management LLC 50,000$595,0000.28%
View complete list of GALMED PHARMACEUTICALS LTD shareholders